000 01390 a2200349 4500
005 20250513103647.0
264 0 _c19970318
008 199703s 0 0 eng d
022 _a0706-7437
024 7 _a10.1177/070674379604100822
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStip, E
245 0 0 _aMemory impairment in schizophrenia: perspectives from psychopathology and pharmacotherapy.
_h[electronic resource]
260 _bCanadian journal of psychiatry. Revue canadienne de psychiatrie
_cOct 1996
300 _aS27-34 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAmnesia
_xchemically induced
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aCholinergic Antagonists
_xadverse effects
650 0 4 _aClozapine
_xadverse effects
650 0 4 _aDibenzothiazepines
_xadverse effects
650 0 4 _aHumans
650 0 4 _aMental Recall
_xdrug effects
650 0 4 _aNeuropsychological Tests
650 0 4 _aQuetiapine Fumarate
650 0 4 _aRetention, Psychology
_xdrug effects
650 0 4 _aRisperidone
_xadverse effects
650 0 4 _aSchizophrenia
_xdiagnosis
650 0 4 _aSchizophrenic Psychology
773 0 _tCanadian journal of psychiatry. Revue canadienne de psychiatrie
_gvol. 41
_gno. 8 Suppl 2
_gp. S27-34
856 4 0 _uhttps://doi.org/10.1177/070674379604100822
_zAvailable from publisher's website
999 _c8891816
_d8891816